Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is This The Collapse of Icahn Enterprises ?: https://www.marketbeat.com/logos/articles/med_20230531120443_is-this-the-collapse-of-icahn-enterprises.jpg
Is This The Collapse of Icahn Enterprises ?

Icahn Enterprises L.P. (NASDAQ: IEP) is a diversified holding company founded in 1987 by famous American Investor Carl Icahn. The company operates in various industries through various

HP Is A Winner For Income Investors: https://www.marketbeat.com/logos/articles/med_20230531095850_chart-hpq-5312023.png
HP Is A Winner For Income Investors

HP (NYSE: HP) is not a growth stock; it’s not exciting to own, but it is a winner if you are an income investor. The business is down, and the outlook isn’t all that rosy, but the business is

A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It: https://www.marketbeat.com/logos/articles/med_20230531104122_mnst-ko.jpg
A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It

The Artificial Intelligence driven ETF (Exchange Traded Fund) AMOM (NYSEARCA: AMOM) has released its latest holdings list, making a surprising pivot into some consumer names and equally unexpected

The Most Upgraded Stocks From The Q1 Earnings Season: https://www.marketbeat.com/logos/articles/med_20230530093742_chart-nvda-crm-5302023.png
The Most Upgraded Stocks From The Q1 Earnings Season

With the Q1 earnings reporting season all but wrapped up, it's time to start looking at the winners and losers from the period. The takeaway from the season is that results are spotty across

UiPath Stock Has Short-Term Pain for Long-Term AI Gain: https://www.marketbeat.com/logos/articles/med_20230528142229_chart-path2.jpg
UiPath Stock Has Short-Term Pain for Long-Term AI Gain

UiPath Inc. (NASDAQ: PATH) shares took an initial dive on its fiscal Q1 earnings release. The culprit was lowered fiscal Q2 2024 revenue guidance that spooked investors. However, the company

New Discovery: Goldflare Obtains 15 g/t Over 7 Meters on the Goldfields Project: https://www.irw-press.at/prcom/images/messages/2023/70771/goldfield05312023_EN_PRcom.002.jpeg
New Discovery: Goldflare Obtains 15 g/t Over 7 Meters on the Goldfields Project

Piedmont (Quebec), May 31st, 2023 – Goldflare Exploration Inc. (TSXV: GOFL) (“Goldflare” or “the Company”) announces the results of three drill holes from a seven (7) drill hole program

Neue Entdeckung: Goldflare erbohrt 15 g/t über 7 Meter auf dem Projekt Goldfields: https://www.irw-press.at/prcom/images/messages/2023/70771/goldfield05312023_DE_PRcom.002.jpeg
Neue Entdeckung: Goldflare erbohrt 15 g/t über 7 Meter auf dem Projekt Goldfields

Piemont (Quebec), 31. Mai 2023 - Goldflare Exploration Inc. (TSXV: GOFL) („Goldflare“ oder „das Unternehmen“) gibt die Ergebnisse aus drei Bohrungen seines sieben (7) Bohrungen (Gesamtlänge

Can Earnings Narrow The Value Gap In Hewlett Packard?: https://www.marketbeat.com/logos/articles/med_20230531072627_can-earnings-narrow-the-value-gap-in-hewlett-packa.jpg
Can Earnings Narrow The Value Gap In Hewlett Packard?

As the chip and semiconductor industry seems to have found new grounds for revolution, as seen in NVIDIA (NASDAQ: NVDA) sporting its new record one trillion-dollar market cap, other names in the

Palantir: The "Sleeper" Play on the AI Revolution: https://www.marketbeat.com/logos/articles/med_20230530110724_palantir-the-sleeper-play-on-the-ai-revolution.jpg
Palantir: The "Sleeper" Play on the AI Revolution

Nvidia CEO Jensen Huang calls ChatGPT's November 2022 release the AI industry's "iPhone moment," triggering an arms race among tech firms, big and small. Microsoft quickly bought half of OpenAI

AI Chip Stock Showdown: The Biggest Winners and Losers: https://www.marketbeat.com/logos/articles/med_20230530104818_ai-chip-stock-showdown-the-biggest-winners-and-los.jpg
AI Chip Stock Showdown: The Biggest Winners and Losers

With the AI boom in full swing, many investors are looking to chip makers as the companies that will proverbially sell picks and shovels in the AI gold rush. The thinking goes that the companies

Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application: https://www.marketbeat.com/logos/articles/med_20230530101326_chart-iova.jpg
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Administration (FDA). The company submitted, and

The Institutions Put A Bottom In Cracker Barrel: https://www.marketbeat.com/logos/articles/med_20230530081156_chart-cbrl-5302023.png
The Institutions Put A Bottom In Cracker Barrel

Cracker  Barrel (NASDAQ: CBRL) stock has been lagging behind its sit-down restaurant peers despite a solid rebound in the industry. Reports from Darden Restaurants International (NYSE: DRI),

Arista Networks Soars As Investors Spot Opportunity After Selloff: https://www.marketbeat.com/logos/articles/med_20230529192544_arista-networks-soars-as-investors-spot-opportunit.jpg
Arista Networks Soars As Investors Spot Opportunity After Selloff

Sometimes when looking at a stock’s chart, you can actually when investors disagree with a selloff. That’s the case with Arista Networks Inc. (NYSE: ANET), which sold off hard after its

The Melt-Up In Marvell Is On; But Don't Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230526091338_chart-mrvl-nvda-5262023.png
The Melt-Up In Marvell Is On; But Don't Chase It Higher

Marvell Technology (NASDAQ: MRVL) started moving higher before the Q1 earnings were released because of results released by NVIDIA (NASDAQ: NVDA). NVIDIA’s results were down compared to last year

A Reversal Is Brewing For Medtronic: Buying The Dip: https://www.marketbeat.com/logos/articles/med_20230525123637_chart-mdt-5252023.png
A Reversal Is Brewing For Medtronic: Buying The Dip

A reversal has been brewing for Medtronic (NYSE: MDT) and healthcare device makers all year. Increasing procedure volume, supply chain normalization, and innovation drive results and underpinning

Ralph Lauren's Styled Dividend Is Still In Season: https://www.marketbeat.com/logos/articles/med_20230525102004_ralph-laurens-styled-dividend-is-still-in-season.jpg
Ralph Lauren's Styled Dividend Is Still In Season

Shares of Ralph Lauren (NYSE: RL) are trading higher on Thursday's trading session, advancing as much as 8.2% amid bullish results from the company's first quarter 2023 earnings. RL stock chart

Upbeat Analysts Project Promising Prospects For Iridium Stock: https://www.marketbeat.com/logos/articles/med_20230525071529_upbeat-analysts-project-promising-prospects-for-ir.jpg
Upbeat Analysts Project Promising Prospects For Iridium Stock

Global satellite communications specialist Iridium Communications Inc. (NASDAQ: IRDM) has a lot going for it. The stock isn't exactly at new heights, but several of its characteristics look

Meet the Nasdaq's 3 Biggest Dividend Payers: https://www.marketbeat.com/logos/articles/med_20230525070240_meet-the-nasdaqs-3-biggest-dividend-payers.jpg
Meet the Nasdaq's 3 Biggest Dividend Payers

The words ‘Nasdaq’ and ‘dividend’ don’t typically go hand in hand. 

It makes sense. The tech-heavy Nasdaq-100 consists largely of cyclical companies that prefer to reinvest profits in growth

Analog Devices Signals A Top For Semiconductor Stocks: https://www.marketbeat.com/logos/articles/med_20230524113233_chart-adi-5242023.png
Analog Devices Signals A Top For Semiconductor Stocks

Analog Devices (NASDAQ: ADI) has been leading the semiconductor market; now, the top is in. The FQ2 results were good enough, but the Q3 guidance is weak and suggests a downturn is coming for the

Pfizer Has the Prescription for Higher Share Prices: https://www.marketbeat.com/logos/articles/med_20230524125944_pfizer-has-the-prescription-for-higher-share-price.jpg
Pfizer Has the Prescription for Higher Share Prices

Pfizer Inc. (NYSE: PFE) released the results of a peer review study that sent shares up more than 5%. The study evaluated the company’s GLP-1 receptor agonist, danuglipron. The compound aimed to

It’s Time To Try On VF Corporation’s 6% Yield: https://www.marketbeat.com/logos/articles/med_20230524093659_copy-1-of-chart-vfc-52420223.png
It’s Time To Try On VF Corporation’s 6% Yield

VF Corporation (NYSE: VFC) has entered a year of change that could lead the stock higher. The company is working to turn around the core brand, Vans, and improve its supply chain and efficiency

2 Tech Mid-Caps Under $10 With Big Upside: https://www.marketbeat.com/logos/articles/med_20230524082119_2-tech-mid-caps-under-10-with-big-upside.jpg
2 Tech Mid-Caps Under $10 With Big Upside

This year’s stock market can be summed up in one word — resilient.

On top of inflationary pressures and rising rates, not even government debt ceiling uncertainty has been able to slow the upward

Microbot Medical spikes 150% on its Endovascular Surgical Robot: https://www.marketbeat.com/logos/articles/med_20230523111957_chart-mbot.jpg
Microbot Medical spikes 150% on its Endovascular Surgical Robot

Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit

BJ's Pulse On Retail Beats Expectations: https://www.marketbeat.com/logos/articles/med_20230523100821_bjs-pulse-on-retail-beats-expectations.jpg
BJ's Pulse On Retail Beats Expectations

BJ's Wholesale Club (NYSE: BJ) reported its first quarter 2023 earnings results on Tuesday morning when the broader stock market index was trading lower by a quarter of a percentage point

Dick’s Sporting Goods Deserves A Higher Price Multiple: https://www.marketbeat.com/logos/articles/med_20230523091047_chart-dks-5232023.png